Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQQ: 45.81 +0.22%   SPY: 110.27 -0.02%
Quote Spy CEGE NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Cell Genesys (CEGE)

@ Oct-14
Click the portfolio to add CEGE:
Close [X]
+ Add CEGE to Portfolio
  
  Last Trade: $0.33 0.00 (0.00%)
  Volume:
       
  Avg Volume: 1,601,000
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.00 - 0.00
  Open: 0.00
  Previous Close: 0.33
  52-wk Range: 0.09 - 0.90
  Market Cap: 35.8M
  P/E: -0.8
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy CEGE

? Pro holders
? Member holders
? Items submitted
Additional CEGE resources



Customize Links
To see which Pros and tickerspy members own CEGE Sign up now
Latest CEGE Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger
CEGE  BPAX  
Linked by BusinessWire - September 22, 06:30PM from (www.businesswire.com)
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that they have determined  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cell Genesys Announces Second Quarter 2009 Financial Results
CEGE  
Linked by BusinessWire - August 05, 06:00AM from (www.businesswire.com)
Cell Genesys, Inc. (NASDAQ:CEGE) today reported financial results for the second quarter 2009. The company reported a net  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biotech & BioHealth Business Daily
BAX  BMY  LLY  MRK  PFE  OSIP  SPPI  CEGE  AVII  GILD  GNBT  BBH  BDSI  SNY  
Linked by 24/7 Wall St. - July 13, 11:25AM from (feedproxy.google.com)
Here are some of today's top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com:
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
CEGE  BPAX  
Linked by BusinessWire - June 30, 08:00AM from (www.businesswire.com)
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and Cell Genesys (NASDAQ:CEGE), today announced that they have entered into  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Healthy Gains for Cancer Treatment Stocks
PPHM  CEGE  EXEL  ONXX  TELK  AEZS  KERX  SNY  
Linked by tickerspy Newswire - May 28, 12:30PM from (www.tickerspy.com)
The cancer therapy sector was up big on Thursday on deal making news and new potential for treatments.
The American  more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Many Biotechs Barely On Life Support
IDMI  NRGN  CEGE  LJPC  NFLDQ  BPAX  EPIX  RPTP  
Linked by 24/7 Wall St. - May 13, 12:31PM from (feedproxy.google.com)
We have run a watch list of companies under their own strategic review, and the number of biotech (or grouped with biotech)  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cell Genesys Announces Plans to Commence Exchange Offer for Its Outstanding 3.125% Convertible Notes
CEGE  
Linked by BusinessWire - May 11, 08:00AM from (www.businesswire.com)
Cell Genesys, Inc. (NASDAQ:CEGE) today announced that the Company expects to commence an exchange offer to exchange all of  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cell Genesys Announces First Quarter 2009 Financial Results
CEGE  
Linked by BusinessWire - April 30, 08:30AM from (www.businesswire.com)
Cell Genesys, Inc. (NASDAQ:CEGE) today reported financial results for the first quarter 2009. The company reported a net  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Best Performing Sectors This Week: Cancer Stocks, Home Furnishing, Aircraft Leasing
PIR  WSM  CEGE  GERN  DNDN  CME  AYR  AER  
Linked by 24/7 Wall St. - April 16, 01:07PM from (feedproxy.google.com)
Based on data fromTickerspy, the best performing market sectors so far this week are cancer stocks, home funishing, and aircraft leasing.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3


Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS